Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.
Pulmonary Surfactant market report explains the definition, types, applications, major countries, and major players of the Pulmonary Surfactant market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Nanjing Norris Pharm Technology
Biorbyt
Windtree Therapeutics
Lyomark Pharma
ONY Biotech
Aviva Systems Biology
Biomatik
AbbVie
Creative Diagnostics
XpressBio
Boehringer Ingelheim
Tekzima (Noargen)
LSBio
Abbott
Reddot Biotech
By Type:
Synthetic Pulmonary Surfactants
Animal Derived Surfactants
By End-User:
Hospital
laboratory
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pulmonary Surfactant Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pulmonary Surfactant Outlook to 2028- Original Forecasts
-
2.2 Pulmonary Surfactant Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pulmonary Surfactant Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pulmonary Surfactant Market- Recent Developments
-
6.1 Pulmonary Surfactant Market News and Developments
-
6.2 Pulmonary Surfactant Market Deals Landscape
7 Pulmonary Surfactant Raw Materials and Cost Structure Analysis
-
7.1 Pulmonary Surfactant Key Raw Materials
-
7.2 Pulmonary Surfactant Price Trend of Key Raw Materials
-
7.3 Pulmonary Surfactant Key Suppliers of Raw Materials
-
7.4 Pulmonary Surfactant Market Concentration Rate of Raw Materials
-
7.5 Pulmonary Surfactant Cost Structure Analysis
-
7.5.1 Pulmonary Surfactant Raw Materials Analysis
-
7.5.2 Pulmonary Surfactant Labor Cost Analysis
-
7.5.3 Pulmonary Surfactant Manufacturing Expenses Analysis
8 Global Pulmonary Surfactant Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pulmonary Surfactant Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pulmonary Surfactant Export by Region (Top 10 Countries) (2017-2028)
9 Global Pulmonary Surfactant Market Outlook by Types and Applications to 2022
-
9.1 Global Pulmonary Surfactant Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Synthetic Pulmonary Surfactants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Animal Derived Surfactants Consumption and Growth Rate (2017-2022)
-
9.2 Global Pulmonary Surfactant Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global laboratory Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pulmonary Surfactant Market Analysis and Outlook till 2022
-
10.1 Global Pulmonary Surfactant Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pulmonary Surfactant Consumption (2017-2022)
-
10.2.2 Canada Pulmonary Surfactant Consumption (2017-2022)
-
10.2.3 Mexico Pulmonary Surfactant Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pulmonary Surfactant Consumption (2017-2022)
-
10.3.2 UK Pulmonary Surfactant Consumption (2017-2022)
-
10.3.3 Spain Pulmonary Surfactant Consumption (2017-2022)
-
10.3.4 Belgium Pulmonary Surfactant Consumption (2017-2022)
-
10.3.5 France Pulmonary Surfactant Consumption (2017-2022)
-
10.3.6 Italy Pulmonary Surfactant Consumption (2017-2022)
-
10.3.7 Denmark Pulmonary Surfactant Consumption (2017-2022)
-
10.3.8 Finland Pulmonary Surfactant Consumption (2017-2022)
-
10.3.9 Norway Pulmonary Surfactant Consumption (2017-2022)
-
10.3.10 Sweden Pulmonary Surfactant Consumption (2017-2022)
-
10.3.11 Poland Pulmonary Surfactant Consumption (2017-2022)
-
10.3.12 Russia Pulmonary Surfactant Consumption (2017-2022)
-
10.3.13 Turkey Pulmonary Surfactant Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pulmonary Surfactant Consumption (2017-2022)
-
10.4.2 Japan Pulmonary Surfactant Consumption (2017-2022)
-
10.4.3 India Pulmonary Surfactant Consumption (2017-2022)
-
10.4.4 South Korea Pulmonary Surfactant Consumption (2017-2022)
-
10.4.5 Pakistan Pulmonary Surfactant Consumption (2017-2022)
-
10.4.6 Bangladesh Pulmonary Surfactant Consumption (2017-2022)
-
10.4.7 Indonesia Pulmonary Surfactant Consumption (2017-2022)
-
10.4.8 Thailand Pulmonary Surfactant Consumption (2017-2022)
-
10.4.9 Singapore Pulmonary Surfactant Consumption (2017-2022)
-
10.4.10 Malaysia Pulmonary Surfactant Consumption (2017-2022)
-
10.4.11 Philippines Pulmonary Surfactant Consumption (2017-2022)
-
10.4.12 Vietnam Pulmonary Surfactant Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pulmonary Surfactant Consumption (2017-2022)
-
10.5.2 Colombia Pulmonary Surfactant Consumption (2017-2022)
-
10.5.3 Chile Pulmonary Surfactant Consumption (2017-2022)
-
10.5.4 Argentina Pulmonary Surfactant Consumption (2017-2022)
-
10.5.5 Venezuela Pulmonary Surfactant Consumption (2017-2022)
-
10.5.6 Peru Pulmonary Surfactant Consumption (2017-2022)
-
10.5.7 Puerto Rico Pulmonary Surfactant Consumption (2017-2022)
-
10.5.8 Ecuador Pulmonary Surfactant Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pulmonary Surfactant Consumption (2017-2022)
-
10.6.2 Kuwait Pulmonary Surfactant Consumption (2017-2022)
-
10.6.3 Oman Pulmonary Surfactant Consumption (2017-2022)
-
10.6.4 Qatar Pulmonary Surfactant Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pulmonary Surfactant Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pulmonary Surfactant Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pulmonary Surfactant Consumption (2017-2022)
-
10.7.2 South Africa Pulmonary Surfactant Consumption (2017-2022)
-
10.7.3 Egypt Pulmonary Surfactant Consumption (2017-2022)
-
10.7.4 Algeria Pulmonary Surfactant Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pulmonary Surfactant Consumption (2017-2022)
-
10.8.2 New Zealand Pulmonary Surfactant Consumption (2017-2022)
11 Global Pulmonary Surfactant Competitive Analysis
-
11.1 Nanjing Norris Pharm Technology
-
11.1.1 Nanjing Norris Pharm Technology Company Details
-
11.1.2 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Main Business and Markets Served
-
11.1.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Biorbyt
-
11.2.1 Biorbyt Company Details
-
11.2.2 Biorbyt Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Biorbyt Pulmonary Surfactant Main Business and Markets Served
-
11.2.4 Biorbyt Pulmonary Surfactant Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Windtree Therapeutics
-
11.3.1 Windtree Therapeutics Company Details
-
11.3.2 Windtree Therapeutics Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Windtree Therapeutics Pulmonary Surfactant Main Business and Markets Served
-
11.3.4 Windtree Therapeutics Pulmonary Surfactant Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Lyomark Pharma
-
11.4.1 Lyomark Pharma Company Details
-
11.4.2 Lyomark Pharma Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Lyomark Pharma Pulmonary Surfactant Main Business and Markets Served
-
11.4.4 Lyomark Pharma Pulmonary Surfactant Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 ONY Biotech
-
11.5.1 ONY Biotech Company Details
-
11.5.2 ONY Biotech Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 ONY Biotech Pulmonary Surfactant Main Business and Markets Served
-
11.5.4 ONY Biotech Pulmonary Surfactant Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Aviva Systems Biology
-
11.6.1 Aviva Systems Biology Company Details
-
11.6.2 Aviva Systems Biology Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Aviva Systems Biology Pulmonary Surfactant Main Business and Markets Served
-
11.6.4 Aviva Systems Biology Pulmonary Surfactant Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Biomatik
-
11.7.1 Biomatik Company Details
-
11.7.2 Biomatik Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Biomatik Pulmonary Surfactant Main Business and Markets Served
-
11.7.4 Biomatik Pulmonary Surfactant Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 AbbVie
-
11.8.1 AbbVie Company Details
-
11.8.2 AbbVie Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 AbbVie Pulmonary Surfactant Main Business and Markets Served
-
11.8.4 AbbVie Pulmonary Surfactant Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Creative Diagnostics
-
11.9.1 Creative Diagnostics Company Details
-
11.9.2 Creative Diagnostics Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Creative Diagnostics Pulmonary Surfactant Main Business and Markets Served
-
11.9.4 Creative Diagnostics Pulmonary Surfactant Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 XpressBio
-
11.10.1 XpressBio Company Details
-
11.10.2 XpressBio Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 XpressBio Pulmonary Surfactant Main Business and Markets Served
-
11.10.4 XpressBio Pulmonary Surfactant Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Boehringer Ingelheim
-
11.11.1 Boehringer Ingelheim Company Details
-
11.11.2 Boehringer Ingelheim Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Boehringer Ingelheim Pulmonary Surfactant Main Business and Markets Served
-
11.11.4 Boehringer Ingelheim Pulmonary Surfactant Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Tekzima (Noargen)
-
11.12.1 Tekzima (Noargen) Company Details
-
11.12.2 Tekzima (Noargen) Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Tekzima (Noargen) Pulmonary Surfactant Main Business and Markets Served
-
11.12.4 Tekzima (Noargen) Pulmonary Surfactant Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 LSBio
-
11.13.1 LSBio Company Details
-
11.13.2 LSBio Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 LSBio Pulmonary Surfactant Main Business and Markets Served
-
11.13.4 LSBio Pulmonary Surfactant Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Abbott
-
11.14.1 Abbott Company Details
-
11.14.2 Abbott Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Abbott Pulmonary Surfactant Main Business and Markets Served
-
11.14.4 Abbott Pulmonary Surfactant Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Reddot Biotech
-
11.15.1 Reddot Biotech Company Details
-
11.15.2 Reddot Biotech Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Reddot Biotech Pulmonary Surfactant Main Business and Markets Served
-
11.15.4 Reddot Biotech Pulmonary Surfactant Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global Pulmonary Surfactant Market Outlook by Types and Applications to 2028
-
12.1 Global Pulmonary Surfactant Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Synthetic Pulmonary Surfactants Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Animal Derived Surfactants Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pulmonary Surfactant Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global laboratory Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pulmonary Surfactant Market Analysis and Outlook to 2028
-
13.1 Global Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.2.2 Canada Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.2 UK Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.3 Spain Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.5 France Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.6 Italy Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.8 Finland Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.9 Norway Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.11 Poland Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.12 Russia Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.2 Japan Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.3 India Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5.3 Chile Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5.6 Peru Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.6.3 Oman Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pulmonary Surfactant Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pulmonary Surfactant Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pulmonary Surfactant
-
Figure of Pulmonary Surfactant Picture
-
Table Global Pulmonary Surfactant Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pulmonary Surfactant Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Synthetic Pulmonary Surfactants Consumption and Growth Rate (2017-2022)
-
Figure Global Animal Derived Surfactants Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global laboratory Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Pulmonary Surfactant Consumption by Country (2017-2022)
-
Table North America Pulmonary Surfactant Consumption by Country (2017-2022)
-
Figure United States Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Canada Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Table Europe Pulmonary Surfactant Consumption by Country (2017-2022)
-
Figure Germany Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure UK Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Spain Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure France Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Italy Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Finland Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Norway Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Poland Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Russia Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Table APAC Pulmonary Surfactant Consumption by Country (2017-2022)
-
Figure China Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Japan Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure India Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Table South America Pulmonary Surfactant Consumption by Country (2017-2022)
-
Figure Brazil Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Chile Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Peru Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Table GCC Pulmonary Surfactant Consumption by Country (2017-2022)
-
Figure Bahrain Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Oman Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Table Africa Pulmonary Surfactant Consumption by Country (2017-2022)
-
Figure Nigeria Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Table Oceania Pulmonary Surfactant Consumption by Country (2017-2022)
-
Figure Australia Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pulmonary Surfactant Consumption and Growth Rate (2017-2022)
-
Table Nanjing Norris Pharm Technology Company Details
-
Table Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanjing Norris Pharm Technology Pulmonary Surfactant Main Business and Markets Served
-
Table Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio
-
Table Biorbyt Company Details
-
Table Biorbyt Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biorbyt Pulmonary Surfactant Main Business and Markets Served
-
Table Biorbyt Pulmonary Surfactant Product Portfolio
-
Table Windtree Therapeutics Company Details
-
Table Windtree Therapeutics Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Windtree Therapeutics Pulmonary Surfactant Main Business and Markets Served
-
Table Windtree Therapeutics Pulmonary Surfactant Product Portfolio
-
Table Lyomark Pharma Company Details
-
Table Lyomark Pharma Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lyomark Pharma Pulmonary Surfactant Main Business and Markets Served
-
Table Lyomark Pharma Pulmonary Surfactant Product Portfolio
-
Table ONY Biotech Company Details
-
Table ONY Biotech Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table ONY Biotech Pulmonary Surfactant Main Business and Markets Served
-
Table ONY Biotech Pulmonary Surfactant Product Portfolio
-
Table Aviva Systems Biology Company Details
-
Table Aviva Systems Biology Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aviva Systems Biology Pulmonary Surfactant Main Business and Markets Served
-
Table Aviva Systems Biology Pulmonary Surfactant Product Portfolio
-
Table Biomatik Company Details
-
Table Biomatik Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomatik Pulmonary Surfactant Main Business and Markets Served
-
Table Biomatik Pulmonary Surfactant Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Pulmonary Surfactant Main Business and Markets Served
-
Table AbbVie Pulmonary Surfactant Product Portfolio
-
Table Creative Diagnostics Company Details
-
Table Creative Diagnostics Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Creative Diagnostics Pulmonary Surfactant Main Business and Markets Served
-
Table Creative Diagnostics Pulmonary Surfactant Product Portfolio
-
Table XpressBio Company Details
-
Table XpressBio Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table XpressBio Pulmonary Surfactant Main Business and Markets Served
-
Table XpressBio Pulmonary Surfactant Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Pulmonary Surfactant Main Business and Markets Served
-
Table Boehringer Ingelheim Pulmonary Surfactant Product Portfolio
-
Table Tekzima (Noargen) Company Details
-
Table Tekzima (Noargen) Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tekzima (Noargen) Pulmonary Surfactant Main Business and Markets Served
-
Table Tekzima (Noargen) Pulmonary Surfactant Product Portfolio
-
Table LSBio Company Details
-
Table LSBio Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table LSBio Pulmonary Surfactant Main Business and Markets Served
-
Table LSBio Pulmonary Surfactant Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Pulmonary Surfactant Main Business and Markets Served
-
Table Abbott Pulmonary Surfactant Product Portfolio
-
Table Reddot Biotech Company Details
-
Table Reddot Biotech Pulmonary Surfactant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reddot Biotech Pulmonary Surfactant Main Business and Markets Served
-
Table Reddot Biotech Pulmonary Surfactant Product Portfolio
-
Figure Global Synthetic Pulmonary Surfactants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Animal Derived Surfactants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global laboratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Table North America Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Figure United States Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Figure Germany Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Figure China Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pulmonary Surfactant Consumption Forecast by Country (2022-2028)
-
Figure Australia Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pulmonary Surfactant Consumption Forecast and Growth Rate (2022-2028)
-
